PDCD1 and cancer: Extracellular vesicles derived from Lactobacillus rhamnosus GG have been shown to modulate intestinal immunity, increase beneficial gut microbiota, and enhance anti-PD-1 therapy efficacy in colorectal cancer models, suggesting a novel avenue for improving cancer immunotherapy through microbiome modulation [167].